Literature DB >> 26355819

Effect of hydrophilic additives on the dissolution and pharmacokinetic properties of itraconazole-enteric polymer hot-melt extruded amorphous solid dispersions.

Bo Lang1, Sha Liu1,2, James W McGinity1, Robert O Williams1.   

Abstract

Hot-melt extrusion technology has been widely reported for producing amorphous solid dispersions of poorly water-soluble compounds. A number of studies revealed that enteric polymers containing ionizable groups are able to improve the physical stability and maintain drug supersaturation, thereby enhancing oral bioavailability. However, our previous studies found that itraconazole (ITZ)-enteric polymer amorphous solid dispersions are hydrophobic and poorly wettable. Moreover, drug release in an acidic environment (i.e. stomach) is very limited, indicating a narrow absorption window. In the present study, we investigated the effect of hydrophilic additives on the in vitro and in vivo performance of ITZ-enteric polymer amorphous solid dispersions. Incorporating Vitamin E TPGS into ITZ-HPMCAS amorphous solid dispersions significantly improved drug release in the acidic media. Surprisingly, a low concentration of Vitamin E TPGS also enhanced the degree of drug supersaturation in neutral pH media, which is unique as compared with other tested hydrophilic additives. This effect is not due to the solubilization of the surfactant. We further formulated the amorphous solid dispersions into tablet dosage forms and evaluated their performance in a bio-relevant dissolution media. Our optimized formulations exhibited drastically enhanced dissolution profiles as compared with the commercial ITZ product and ITZ amorphous solid dispersion without hydrophilic additive. In vivo study showed that Vitamin E TPGS induced rapid drug absorption after oral administration. Moreover, the elimination half-life of ITZ was prolonged due to the enzyme inhibition effect of Vitamin E TPGS.

Entities:  

Keywords:  Glass transition temperature; TPGS; miscibility; supersaturation; tablet

Mesh:

Substances:

Year:  2015        PMID: 26355819     DOI: 10.3109/03639045.2015.1075031

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  8 in total

1.  Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection.

Authors:  Julien P Maincent; Laura K Najvar; William R Kirkpatrick; Siyuan Huang; Thomas F Patterson; Nathan P Wiederhold; Jay I Peters; Robert O Williams
Journal:  Drug Dev Ind Pharm       Date:  2016-10-05       Impact factor: 3.225

2.  An Insight into Eudragit S100 Preserving Mechanism of Cinnarizine Supersaturation.

Authors:  Maryam Maghsoodi; Saeideh Mollaie Astemal; Ali Nokhodchi; Hossein Kiaie; Ali Baradar Khoshfetrat; Fatemeh Talebi
Journal:  AAPS PharmSciTech       Date:  2022-03-01       Impact factor: 3.246

3.  Synergistic Antifungal Activity of Synthetic Peptides and Antifungal Drugs against Candida albicans and C. parapsilosis Biofilms.

Authors:  Leandro P Bezerra; Cleverson D T Freitas; Ayrles F B Silva; Jackson L Amaral; Nilton A S Neto; Rafael G G Silva; Aura L C Parra; Gustavo H Goldman; Jose T A Oliveira; Felipe P Mesquita; Pedro F N Souza
Journal:  Antibiotics (Basel)       Date:  2022-04-21

Review 4.  The Need for Restructuring the Disordered Science of Amorphous Drug Formulations.

Authors:  Khadijah Edueng; Denny Mahlin; Christel A S Bergström
Journal:  Pharm Res       Date:  2017-05-18       Impact factor: 4.200

5.  Development of Liposome containing sodium deoxycholate to enhance oral bioavailability of itraconazole.

Authors:  Zhenbao Li; Meiyu Zhang; Chang Liu; Shiwei Zhou; Wenjuan Zhang; Tianyang Wang; Mei Zhou; Xiaohong Liu; Yongjun Wang; Yinghua Sun; Jin Sun
Journal:  Asian J Pharm Sci       Date:  2016-08-04       Impact factor: 6.598

6.  Extrapolating Antifungal Animal Data to Humans - Is it reliable?

Authors:  Victoria M Stevens; Scott W Mueller; Paul M Reynolds; Robert MacLaren; Tyree H Kiser
Journal:  Curr Fungal Infect Rep       Date:  2020-01-16

7.  Exploring the Role of Surfactants in Enhancing Drug Release from Amorphous Solid Dispersions at Higher Drug Loadings.

Authors:  Sugandha Saboo; Pradnya Bapat; Dana E Moseson; Umesh S Kestur; Lynne S Taylor
Journal:  Pharmaceutics       Date:  2021-05-17       Impact factor: 6.321

8.  Drug crystal growth in ternary amorphous solid dispersions: Effect of surfactants and polymeric matrix-carriers.

Authors:  Afroditi Kapourani; Theodora Tzakri; Vasiliki Valkanioti; Konstantinos N Kontogiannopoulos; Panagiotis Barmpalexis
Journal:  Int J Pharm X       Date:  2021-06-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.